Sleepiz AG
- Industry
- Medtech
- Founded Year
- 2018
- Headquarters
- Zurich, Switzerland
- Employee Count
- 65
Key People
- Soumya Sunder Dash - Co-Founder & CEO
- Max Sieghold - Co-Founder & CFO
- Marc Rullan - Co-Founder & CTO
- Robb LaChappelle - VP, Sleepiz USA
- Ankita Arora - VP, Indian Operations
- Jonas Krauss - VP, Business
- Marta Stepien - VP, Clinical, Regulatory & Quality Affairs
- Dhiresh Gullapalli - Front End Lead
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in engineering, finance, and healthcare.
The co-founders and key executives bring a wealth of experience from various sectors, enhancing the company's capability to navigate the MedTech landscape effectively.
- Clinical Need
-
Aspect: Very Strong
Summary: Sleepiz addresses a significant unmet need in non-contact vital sign monitoring, particularly for sleep apnea diagnosis.
By providing a contactless monitoring device, Sleepiz enhances patient compliance and enables early detection and management of sleep-related disorders.
- Competition
-
Aspect: First mover
Summary: Sleepiz is among the pioneers in contactless sleep monitoring, with limited direct competition.
While there are other sleep monitoring solutions, Sleepiz's non-contact technology differentiates it, offering a unique value proposition.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate non-contact monitoring technology presents moderate technical challenges.
Ensuring the device's precision in diverse home environments necessitates ongoing research and development efforts.
- Patent
-
Aspect: Strong
Summary: Sleepiz holds strong patents protecting its core technology.
Robust intellectual property rights safeguard the company's innovations, supporting long-term market positioning.
- Financing
-
Aspect: Well-funded
Summary: Sleepiz has secured significant funding from reputable investors.
With a Series A funding of CHF 4.4 million and additional non-dilutive funding, Sleepiz is well-positioned for growth.
- Regulatory
-
Aspect: 510k/PMA + Reimbursement
Summary: The device has received FDA clearance and CE Class IIa certification.
Achieving these certifications demonstrates the device's safety and efficacy, essential for adoption in clinical settings.
Opportunity Rollup
- Odds of Success
- 4.45
- Peak Market Share
- 6.15
- Segment CAGR
- 3.6%
- Market Segment
- Patient Monitoring
- Market Sub Segment
- Sleep Monitoring Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.31 |
| 2 | 0.92 |
| 3 | 2.15 |
| 4 | 4.30 |
| 5 | 6.15 |
Key Takeaway
Sleepiz AG is well-positioned in the growing patient monitoring market with its innovative non-contact sleep monitoring device, supported by a strong team, robust funding, and key regulatory approvals.